Arlington, MA, United States of America

Christopher John Corcoran

USPTO Granted Patents = 15 

 

 

Average Co-Inventor Count = 5.9

ph-index = 4

Forward Citations = 56(Granted Patents)


Company Filing History:


Years Active: 2006-2019

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):

Title: Innovator Spotlight: Christopher John Corcoran

Introduction: Christopher John Corcoran is a notable inventor based in Arlington, MA, whose contributions to the field of biotechnology have resulted in an impressive portfolio of 15 patents. His work primarily focuses on the development of novel therapeutics related to growth and differentiation factor-8 (GDF8), which plays a crucial role in various physiological processes.

Latest Patents: One of his most significant patents is titled "Antibody to GDF8 and uses thereof." This invention discloses novel molecules associated with GDF8, specifically targeting epitopes and other antagonists such as anti-GDF8 antibodies. These advancements have potential applications in inhibiting GDF8 activity and signaling both in vitro and in vivo. The patent also elaborates on an immunoassay designed for the detection and quantification of GDF8, along with methods for diagnosing, preventing, ameliorating, and treating GDF8-associated disorders. Such disorders may include degenerative issues pertaining to muscle, bone, and insulin metabolism. Furthermore, the patent addresses the development of pharmaceuticals utilizing antibodies, polypeptides, polynucleotides, and vectors derived from this innovation.

Career Highlights: Christopher's professional journey includes significant positions at notable companies such as Wyeth and Pfizer Corporation. His tenure at these leading pharmaceutical firms has undoubtedly contributed to his expertise and innovative capacity in the field of biotech.

Collaborations: Throughout his career, Christopher has collaborated with esteemed colleagues including Lisa Anne Collins-Racie and Bethany Annis Freeman. These partnerships have fostered an environment of shared knowledge and teamwork, propelling their collective work in medical innovation.

Conclusion: Christopher John Corcoran's dedication to advancing biotech through his numerous patents reflects his innovative spirit and commitment to addressing critical health challenges. His work with GDF8 illustrates the profound impact that dedicated inventors can have on the medical field, paving the way for future breakthroughs in therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…